![]() Kedrion Biopharma Kedrion Biopharma is a biopharmaceutical company that develops and produces plasma-derived therapies. | ![]() Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. | YiChang HEC ChangJiang Pharmaceutical YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2001 | Founding Date 1909 | Founding Date 2011 | Founding Date 2001 | Founding Date 1985 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Fort Lee, US HQ Bolognana, IT Algés, PT Zug, CH | Locations Sant Cugat del Vallès, ES HQ Buenos Aires, AR Clayton South, AU São Paulo, BR Mississauga, CA Las Condes, CL see more | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US | Locations HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 2,3532% increase | Employees 23,800 | Employees 5,3942% increase | Employees 4,595 | Employees 9,067 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 6.7 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.5b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥3.7b (FY, 2024) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €4.2b (FY, 2025) | Cost of goods N/A | Cost of goods ¥533.6m (FY, 2024) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit N/A | Gross profit ¥3.2b (FY, 2024) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income N/A | Net income €500m (FY, 2025) | Net income N/A | Net income ¥482.7m (FY, 2024) | Net income ¥2.4b (FY, 2025) |

Grifols is a pharmaceutical and chemical manufacturer.
View company
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View companyYiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products.
View companyLivzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company